Diazepam Binding Inhibitor Protein (DBI) (Transcript Variant 1) (Myc-DYKDDDDK Tag)

Produktnummer ABIN2719235

Recombinant Diazepam Binding Inhibitor-Protein exprimiert in HEK-293 Cells.

Kurzübersicht für Diazepam Binding Inhibitor Protein (DBI) (Transcript Variant 1) (Myc-DYKDDDDK Tag) (ABIN2719235)

Target: Diazepam Binding Inhibitor (DBI)

Protein-Typ: Recombinant

Spezies: Human

Quelle: HEK-293 Cells

Applikation: Antibody Production (AbP), Standard (STD)

Reinheit: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Produktdetails

Proteineigenschaft: Transcript Variant 1

Aufreinigungstag / Konjugat: Dieses Diazepam Binding Inhibitor Protein ist gelabelt mit Myc-DYKDDDDK Tag.

Produktmerkmale:

• Recombinant human DBI / ACBP (transcript variant 1) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Kommentare:

The tag is located at the C-terminal.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: Diazepam Binding Inhibitor (DBI)

Andere Bezeichnung: Dbi,acbp

Hintergrund: Binds medium- and long-chain acyl-CoA esters with very high affinity and may function as an intracellular carrier of acyl-CoA esters. It is also able to displace diazepam from the benzodiazepine (BZD) recognition site located on the GABA type A receptor. It is therefore possible that this protein also acts as a neuropeptide to modulate the action of the GABA receptor. [UniProtKB/Swiss-Prot Function]

Molekulargewicht: 11.6 kDa

NCBI Accession: NP_065438